These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 28092102)
21. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks. Shirafkan N; Mansoori B; Mohammadi A; Shomali N; Ghasbi M; Baradaran B Biomed Pharmacother; 2018 Jan; 97():1319-1330. PubMed ID: 29156521 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients. Ak S; Tunca B; Tezcan G; Cecener G; Egeli U; Yilmazlar T; Ozturk E; Yerci O J Surg Res; 2014 Sep; 191(1):113-22. PubMed ID: 24746948 [TBL] [Abstract][Full Text] [Related]
23. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis. Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381 [TBL] [Abstract][Full Text] [Related]
25. A panel of microRNA signature in serum for colorectal cancer diagnosis. Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881 [TBL] [Abstract][Full Text] [Related]
26. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol. Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696 [TBL] [Abstract][Full Text] [Related]
27. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer. Hibner G; Kimsa-Furdzik M; Francuz T Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723 [TBL] [Abstract][Full Text] [Related]
28. Systematic analysis of key miRNAs and related signaling pathways in colorectal tumorigenesis. Yin Y; Song M; Gu B; Qi X; Hu Y; Feng Y; Liu H; Zhou L; Bian Z; Zhang J; Zuo X; Huang Z Gene; 2016 Mar; 578(2):177-84. PubMed ID: 26692142 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA biomarkers predicting risk, initiation and progression of colorectal cancer. Lee K; Ferguson LR World J Gastroenterol; 2016 Sep; 22(33):7389-401. PubMed ID: 27672263 [TBL] [Abstract][Full Text] [Related]
30. Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer. Hata T; Mokutani Y; Takahashi H; Inoue A; Munakata K; Nagata K; Haraguchi N; Nishimura J; Hata T; Matsuda C; Murata K; Mizushima T; Doki Y; Mori M; Yamamoto H Int J Oncol; 2017 Feb; 50(2):487-496. PubMed ID: 28000854 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway. Lu D; Yao Q; Zhan C; Le-Meng Z; Liu H; Cai Y; Tu C; Li X; Zou Y; Zhang S Oncotarget; 2017 Apr; 8(14):22674-22684. PubMed ID: 28186967 [TBL] [Abstract][Full Text] [Related]
32. miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer. Noguchi T; Toiyama Y; Kitajima T; Imaoka H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Toden S; Kusunoki M Oncology; 2016; 90(4):221-31. PubMed ID: 26999740 [TBL] [Abstract][Full Text] [Related]
33. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Tokarz P; Blasiak J Acta Biochim Pol; 2012; 59(4):467-74. PubMed ID: 23173124 [TBL] [Abstract][Full Text] [Related]
34. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer. Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y Oncology; 2017; 92(6):360-370. PubMed ID: 28376502 [TBL] [Abstract][Full Text] [Related]
35. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer. Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276 [TBL] [Abstract][Full Text] [Related]
36. Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer. Qin YZ; Xie XC; Liu HZ; Lai H; Qiu H; Ge LY Oncol Rep; 2015 Jun; 33(6):2728-36. PubMed ID: 25845814 [TBL] [Abstract][Full Text] [Related]
37. MicroRNAs expression profiling in Egyptian colorectal cancer patients. Bader El Din NG; Ibrahim MK; El-Shenawy R; Salum GM; Farouk S; Zayed N; Khairy A; El Awady M IUBMB Life; 2020 Feb; 72(2):275-284. PubMed ID: 31512372 [TBL] [Abstract][Full Text] [Related]
38. Identification of microRNA-181 as a promising biomarker for predicting the poor survival in colorectal cancer. Peng Q; Yao W; Yu C; Zou L; Shen Y; Zhu Y; Cheng M; Feng Z; Xu B Cancer Med; 2019 Oct; 8(13):5995-6009. PubMed ID: 31448575 [TBL] [Abstract][Full Text] [Related]
39. Oncogenic miRNAs and target therapies in colorectal cancer. Saberinia A; Alinezhad A; Jafari F; Soltany S; Akhavan Sigari R Clin Chim Acta; 2020 Sep; 508():77-91. PubMed ID: 32407782 [TBL] [Abstract][Full Text] [Related]
40. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Ma Y; Zhang P; Yang J; Liu Z; Yang Z; Qin H Int J Cancer; 2012 May; 130(9):2077-87. PubMed ID: 21671476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]